Latest: The need for reproducible and standardized metrics for SARS-CoV-2: What we learned from...
Latest: Immuno-oncology: Explore the future of cancer therapy
Latest: From tiny particles to big success: KNAUER awarded the Innovation Prize for Berlin...
Latest: MOBILion Systems rolls out red carpet for MOBIE at hometown American Society for Mass...
Latest: ‘Challenges are easier to overcome if you collaborate’
Latest: Seamless food and beverage testing: There’s an app for that
Latest: LevitasBio announces new approaches to sample preparation and cell enrichment
The need for reproducible and standardized metrics for SARS-CoV-2: What we learned from COVID-19
‘Lab product reviews are an invaluable companion to my research’
Moderna edges out Pfizer vaccine in head-to-head comparison
New study predicts how SARS-CoV-2 evades vaccines
5 top trending videos on cell culture studies
5 upcoming webinars to accelerate your research
A guide to efficient and greener cannabinoid purification
Increasing LC-MS accessibility for streamlined biotherapeutic analysis
Increased sample throughput for organochlorine pesticides analysis
Flexible sample management for life science laboratories
eLabJournal: More than just an electronic notebook
Immtox 270 Brochure
Biophysical Characterization Technology
How to buy next-generation sequencing
Virtual Clinical Science Summit
Virtual Cancer & Immunology Research Summit
05 Feb 22 - 09 Feb 22
Analytical Science Summit...
14 Feb 22 - 15 Feb 22
NEW: Infectious Disease &...
01 Mar 22 - 07 Mar 22
04 Apr 22 - 08 Apr 22
09 May 22 - 13 May 22
3D ex vivo platforms have been diligently evaluated as better predictive tools in research and the preclinical and clinical space in the quest for reducing the dependence on animal research.